BP delays investor day after CEO’s medical procedure, sees lower Q4 upstream production


BP Filling Station Signage

Oli Scarff/Getty Images News

BP (NYSE:BP) -1.3% pre-market Tuesday after saying Q4 results will be hurt by lower oil and gas production, refining margins and trading, while also delaying its investor day due to a planned medical procedure by CEO Murray Auchincloss.

The company said CEO


Leave a Comment